Literature DB >> 2143488

Inhibition of cytokine-induced MHC class II but not class I molecule expression on mouse islet cells by niacinamide and 3-aminobenzamide.

K Yamada1, E Miyajima, K Nonaka.   

Abstract

Normal mouse islet cells express low levels of MHC class I molecules and undetectable or extremely low levels of MHC class II molecules. Class I expression was dose-dependently augmented by incubation with interferon-gamma (IFN-gamma) or tumor necrosis factor (TNF). Although neither IFN-gamma nor TNF alone induce class II molecules on islet cells, synergistic interaction of IFN-gamma (200 U/ml) and TNF (200 U/ml) may induce class II expression on approximately 50% of islet cells. Niacinamide and 3-aminobenzamide, both inhibitors of ADP ribosylation and scavengers of free radicals, attenuated the class II expression induced by IFN-gamma and TNF. Twenty millimolar niacinamide and 10 mM 3-aminobenzamide reduced the rates of class II antigen-positive cells to mean +/- SD 3.6 +/- 0.3 and 6.1 +/- 1.9%, respectively. The agents did not affect the cytokine-induced augmentation of class I antigens. The inhibition of class II molecule expression may at least partly account for the preventive effect of niacinamide on autoimmune-associated beta-cell damage in NOD mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143488     DOI: 10.2337/diab.39.9.1125

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Composition of human islet cell preparations for transplantation.

Authors:  C E Sever; A J Demetris; J Zeng; P Carroll; A Tzakis; J J Fung; T E Starzl; C Ricordi
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

2.  Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells.

Authors:  T Otonkoski; G M Beattie; M I Mally; C Ricordi; A Hayek
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

3.  Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes.

Authors:  U Walter; T Toepfer; K E J Dittmar; K Kretschmer; J Lauber; S Weiss; G Servos; O Lechner; W A Scherbaum; S R Bornstein; H Von Boehmer; J Buer
Journal:  Diabetologia       Date:  2003-07-10       Impact factor: 10.122

4.  Effect of nicotinamide on early graft failure following intraportal islet transplantation.

Authors:  Da-Yeon Jung; Jae Berm Park; Sung-Yeon Joo; Jae-Won Joh; Choon-Hyuck Kwon; Ghee-Young Kwon; Sung-Joo Kim
Journal:  Exp Mol Med       Date:  2009-11-30       Impact factor: 8.718

5.  Inhibitory effects of nicotinamide on intercellular adhesion molecule-1 expression on cultured human thyroid cells.

Authors:  Y Hiromatsu; M Sato; K Tanaka; N Ishisaka; J Kamachi; K Nonaka
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

6.  Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide.

Authors:  R B Elliott; H P Chase
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.